ArticleActa odontologica latinoamericana : AOL2026
Comparative Analysis of Graph Attention and Graph Convolutional Networks for Predicting Candidate SNP-miRNA-DrugInteractions in Integrated Regulatory Datasets.
Article in Acta odontologica latinoamericana : AOL, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex genetic and epigenetic factors, such as single-nucleotide polymorphisms (SNPs) that influence the function of microRNAs (miRNAs), are involved in periodontal inflammation and tissue regeneration. However, computational approaches for predicting potential SNP-miRNA interactions that may influence inflammatory signaling and drug responses remain limited in precision periodontology.
aimTo implement and compare two graph neural network-based machine learning models-Graph Attention Network (GAT) and Graph Convolutional Network (GCN)- for predicting potential SNP-miRNA-drug interactions that may be relevant to inflammatory and regenerative pathways associated with periodontal disease. MATERIALS AND
methodSNPs found in miRNA precursor and target regions associated with immune and drug-response genes were included in three selected miRNA SNP v3.0 database datasets. After preprocessing, composite vectors were created by early fusion of heterogeneous features. Principal component analysis (PCA) was then used to normalize and reduce the composite vectors. Using matched hyperparameters, the GAT and GCN models were built in PyTorch Geometric and trained with cross-entropy loss. Regression metrics (RMSE, MAE, R2) and classification metrics (accuracy, precision, recall, F1-score, ROC-AUC, PR-AUC) were used to evaluate performance.
resultsWith a perfect recall (1.0), F1-score of 0.666, and PR-AUC of 0.750, GAT performed better in classification than GCN, demonstrating higher sensitivity for identifying candidate interactions within the integrated dataset. Although R2 values were close to zero, indicating limited variance explanation, regression performance was comparable for both models (RMSE ≈ 0.524). Visual diagnostics showed that GAT maintained more prediction variability, while GCN predictions collapsed around mean values.
conclusionsBecause of its attention-based architecture, GAT showed improved performance in classification metrics compared with GCN, suggesting potential advantages for prioritizing candidate SNP-miRNA-drug interactions within integrated regulatory datasets. However, the limited predictive performance observed indicates that these findings should be interpreted primarily as a comparative computational evaluation rather than as direct biological evidence. Future studies incorporating periodontalspecific molecular datasets and experimentally validated interactions will be necessary to improve biological interpretability and translational relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.